(19)
(11) EP 4 823 564 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24904785.3

(22) Date of filing: 11.12.2024
(51) International Patent Classification (IPC): 
A61K 31/395(2006.01)
A61K 31/47(2006.01)
A61K 31/33(2006.01)
 A61K 31/44(2006.01)
A61K 31/435(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/444; A61K 31/4525; A61K 31/138; A61K 31/49
 
C-Sets:
  1. A61K 31/444, A61K 2300/00;
  2. A61K 31/4525, A61K 2300/00;
  3. A61K 31/138, A61K 2300/00;
  4. A61K 31/49, A61K 2300/00;
(86) International application number:
PCT/US2024/059514
(87) International publication number:
WO 2025/128666 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 11.12.2023 US 202363608676 P

(71) Applicant: BioXcel Therapeutics, Inc.
New Haven, CT 06511 (US)

(72) Inventors:
  • DE VIVO, Michael
    New Haven, Connecticut 06511 (US)
  • ADEDOYIN, Adedayo
    New Haven, Connecticut 06511 (US)
  • SWAMINATHAN, Vidya
    New Haven, Connecticut 06511 (US)
  • SETH, Subhendu
    Gurgaon, Haryana 122002 (IN)
  • DHULL, Dinesh Kumar
    Gurgaon, Haryana 122002 (IN)

(74) Representative: Cooley (UK) LLP 
22 Bishopsgate
London EC2N 4BQ
London EC2N 4BQ (GB)

   


(54) COMBINATION OF LATREPIRDINE AND A PHARMACOKINETIC STABILIZER